Abstract
The Objectives: safety of blood products is one of the major issues in the area of transfusion medicine. In previous study we found that hepatitis B virus was epidemic in some of Basrah medical institutions to assess the prevalence of anti-HBc and anti-HBs antibodies in serum samples of healthy blood donors negative for both HBsAg and anti-HCV in the Central Blood Bank, Basrah-Iraq. Results: 204 serum samples negative for both HBsAg and anti-HCV collected from healthy blood donors were tested for the presence of HBsAg, anti-HBs, HBeAg, anti-HBe and anti-HBc by using rapid chromatographic immunoassay. Of the 204 samples tested, 13 (6.37%) of the HBsAg negative blood samples were found to be positive for anti-HBc. 3(1.47%) out of 13 anti-HBc positive were found positive for anti-HBs. Conclusion: detection of anti-HBc and anti-HBs antibodies were more important than other markers in detection of latent Hepatitis B virus infection.
Highlights
Hepatitis B (HBV) is an indolent disease that seldom causes symptoms until complications of cirrhosis and liver cancer occur.[1]
In previous study[8] we found that the the world's population have had contact with or hepatitis B virus was really societyare carriers of the HBV
This corresponds to an threatening and epidemic in some of the Basra estimated 350 million HBV carriers and medical institutions in dialysis and around one million persons die of HBV-related oncology units
Summary
Hepatitis B (HBV) is an indolent disease that seldom causes symptoms until complications of cirrhosis and liver cancer occur.[1]. Hepatitis B (HBV) is an indolent disease that seldom causes symptoms until complications of cirrhosis and liver cancer occur.[1] It is estimated that 40% of infections but lost detectable anti-HBs antibodies.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
